PAHC · NASDAQ
Phibro Animal Health (PAHC) Stock Price & Fundamentals
Phibro Animal Health (PAHC) closed at $296.66 on Oct 9, 2026, down 0.19% from the previous close of $297.21.
Share price, past year
1Y −4.71%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $296.66 |
| Sep 30, 2026 | $296.12 |
| Aug 31, 2026 | $304.53 |
| Jul 31, 2026 | $300.39 |
| Jun 30, 2026 | $308.80 |
| May 29, 2026 | $327.56 |
| Apr 30, 2026 | $319.67 |
| Mar 31, 2026 | $321.03 |
| Feb 27, 2026 | $329.36 |
| Jan 30, 2026 | $314.69 |
| Dec 31, 2025 | $301.34 |
| Nov 28, 2025 | $306.74 |
| Oct 31, 2025 | $298.55 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 122.1
- EPS (TTM)
- $2.43
- Revenue (TTM)
- $1.52B
- Net income (TTM)
- $99.72M
- Shares outstanding
- 68.9M
- Dividend yield
- 0.16%
- 52-week range
- $290.77 – $334.03
Financials
Phibro Animal Health reported revenue of $1.52B for fiscal 2026, up 17.12% from fiscal 2025.
Phibro Animal Health earned net income of $99.72M in fiscal 2026, a net margin of 6.6%.
Fiscal 2026 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $1.52B | +17.1% | $99.72M | 6.6% | $2.43 | — |
| FY2025ended Jun 30, 2025 | $1.30B | +27.4% | $48.26M | 3.7% | $1.19 | — |
| FY2024ended Jun 30, 2024 | $1.02B | +4.1% | $2.42M | 0.2% | $0.06 | — |
| FY2023ended Jun 30, 2023 | $977.89M | +3.8% | $32.61M | 3.3% | $0.81 | — |
| FY2022ended Jun 30, 2022 | $942.26M | +13.1% | $49.18M | 5.2% | $1.21 | — |
| FY2021ended Jun 30, 2021 | $833.35M | +4.1% | $54.39M | 6.5% | $1.34 | — |
| FY2020ended Jun 30, 2020 | $800.35M | −3.3% | $33.55M | 4.2% | $0.83 | — |
| FY2019ended Jun 30, 2019 | $828.00M | +1.0% | $54.71M | 6.6% | $1.35 | — |
| FY2018ended Jun 30, 2018 | $819.98M | +7.3% | $64.88M | 7.9% | $1.61 | — |
| FY2017ended Jun 30, 2017 | $764.28M | — | $64.62M | 8.5% | $1.61 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2026ended Jun 30, 2026 | $396.75M | $21.71M | $0.52 |
| Q3 FY2026ended Mar 31, 2026 | $383.54M | $24.02M | $0.59 |
| Q2 FY2026ended Dec 31, 2025 | $373.91M | $27.46M | $0.67 |
| Q1 FY2026ended Sep 30, 2025 | $363.89M | $26.53M | $0.65 |
| Q4 FY2025ended Jun 30, 2025 | $378.70M | $17.22M | $0.43 |
| Q3 FY2025ended Mar 31, 2025 | $347.83M | $20.88M | $0.51 |
| Q2 FY2025ended Dec 31, 2024 | $309.26M | $3.19M | $0.08 |
| Q1 FY2025ended Sep 30, 2024 | $260.43M | $6.98M | $0.17 |
Company profile
- Name
- Phibro Animal Health Corporation
- Ticker
- PAHC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666
- Incorporated in
- DE
- Fiscal year ends
- June
- SEC CIK
- 0001069899
Recent SEC filings
- Aug 26, 2026
- Aug 26, 2026
- Jul 28, 2026
- Jun 26, 2026
- May 6, 2026
- May 6, 2026
- May 5, 2026
- Apr 30, 2026
Frequently asked questions
What is Phibro Animal Health's stock price?
Phibro Animal Health (PAHC) closed at $296.66 on Oct 9, 2026, down 0.19% from the previous close of $297.21.
How much revenue does Phibro Animal Health make?
Phibro Animal Health reported revenue of $1.52B for fiscal 2026, up 17.12% from fiscal 2025.
What is PAHC's P/E ratio?
Phibro Animal Health's price-to-earnings ratio is 122.1, based on trailing twelve-month diluted EPS of $2.43.
Does Phibro Animal Health pay a dividend?
Yes. Phibro Animal Health declared $0.48 per share in dividends over the last four quarters, a yield of 0.16%.
Sources and methodology
Fundamentals come from Phibro Animal Health Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures